Select Cognition Coverage and Published Editorials
Oral Small Molecule Shows Promise in Dementia with Lewy Bodies
Healio
December 23, 2024
CT1812 Meets Primary End Point in Phase 2 SHIMMER Study for Dementia with Lewy Bodies
Neurology Live
By Isabella Ciccone, MPH
December 21, 2024
Topline Results Are In: Cognition Therapeutics’ Drug To Fight Dementia With Lewy Bodies Shows Encouraging Results In Phase 2 Trial
Benzinga
By Meg Flippin
December 19, 2024
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld Today
By Randy Osborne
December 18, 2024
Cognition’s phase 2 SHIMMER results finally allow dementia drug to shine
Fierce Biotech
By James Waldron
December 18, 2024
Exploring Innovative Approaches in Alzheimer’s and Dementia Treatment
Clinical Trial Vanguard
By Moe Alsumidaie
November 26, 2024